MolBridge: Atom-Level Joint Graph Refinement for Robust Drug-Drug Interaction Event Prediction

• URL: http://arxiv.org/abs/2510.20448v2
• Date: Fri, 24 Oct 2025 02:34:05 GMT
• Title: MolBridge: Atom-Level Joint Graph Refinement for Robust Drug-Drug Interaction Event Prediction
• Authors: Xuan Lin, Aocheng Ding, Tengfei Ma, Hua Liang, Zhe Quan,
• Abstract summary: Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs)<n>This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.
• Score: 10.392084347375963
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs), especially under complex molecular structures. Accurate DDI event prediction requires capturing fine-grained inter-drug relationships, which are critical for modeling metabolic mechanisms such as enzyme-mediated competition. However, existing approaches typically rely on isolated drug representations and fail to explicitly model atom-level cross-molecular interactions, limiting their effectiveness across diverse molecular complexities and DDI type distributions. To address these limitations, we propose MolBridge, a novel atom-level joint graph refinement framework for robust DDI event prediction. MolBridge constructs a joint graph that integrates atomic structures of drug pairs, enabling direct modeling of inter-drug associations. A central challenge in such joint graph settings is the potential loss of information caused by over-smoothing when modeling long-range atomic dependencies. To overcome this, we introduce a structure consistency module that iteratively refines node features while preserving the global structural context. This joint design allows MolBridge to effectively learn both local and global interaction outperforms state-of-the-art baselines, achieving superior performance across long-tail and inductive scenarios. patterns, yielding robust representations across both frequent and rare DDI types. Extensive experiments on two benchmark datasets show that MolBridge consistently. These results demonstrate the advantages of fine-grained graph refinement in improving the accuracy, robustness, and mechanistic interpretability of DDI event prediction.This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.

Related papers

• Rethinking Drug-Drug Interaction Modeling as Generalizable Relation Learning [14.217488560342135]
  Drug-drug interaction (DDI) prediction is central to drug discovery and clinical development.<n>We propose GenRel-DDI, a relation-centric learning framework that reformulates DDI prediction as a relation-centric learning problem.<n>Experiments show that GenRel-DDI consistently and significantly outperforms state-of-the-art methods.
  arXiv  Detail & Related papers  (2026-01-22T09:00:30Z)
• Towards Interpretable Drug-Drug Interaction Prediction: A Graph-Based Approach with Molecular and Network-Level Explanations [3.6099926707292793]
  Drug-drug interactions (DDIs) represent a critical challenge in pharmacology, often leading to adverse drug reactions with significant implications for patient safety and healthcare outcomes.<n>We propose MolecBioNet, a novel graph-based framework that integrates molecular and biomedical knowledge for robust and interpretable DDI prediction.
  arXiv  Detail & Related papers  (2025-07-12T07:43:19Z)
• Addressing Model Overcomplexity in Drug-Drug Interaction Prediction With Molecular Fingerprints [0.0]
  Accurately predicting drug-drug interactions (DDIs) is crucial for pharmaceutical research and clinical safety.<n>Recent deep learning models often suffer from high computational costs and limited generalization across datasets.<n>In this study, we investigate a simpler yet effective approach using molecular representations such as Morgan fingerprints (S), graph-based embeddings from graph convolutional networks (GCNs), and transformer-derived embeddings from MoLFormer integrated into a straightforward neural network.
  arXiv  Detail & Related papers  (2025-03-30T18:27:01Z)
• MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation [64.4838301776267]
  Multi-channel Interaction Network (MIN) is a novel framework designed to predict drug-target interaction (DTI)<n>MIN incorporates a representation learning module and a multi-channel interaction module.<n>MIN is not only a potent tool for DTI prediction but also offers fresh insights into the prediction of protein binding sites.
  arXiv  Detail & Related papers  (2024-11-23T05:38:36Z)
• DDIPrompt: Drug-Drug Interaction Event Prediction based on Graph Prompt Learning [15.69547371747469]
  DDIPrompt is an innovative solution inspired by the recent advancements in graph prompt learning. Our framework aims to address these issues by leveraging intrinsic the knowledge from pre-trained models. Extensive experiments on two benchmark datasets demonstrate DDIPrompt's SOTA performance.
  arXiv  Detail & Related papers  (2024-02-18T06:22:01Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction [10.157966744159491]
  Concomitant administration of drugs can cause drug-drug interactions (DDIs) We propose a novel model, Molecular Substructure-Aware Network (MSAN), to effectively predict potential DDIs from molecular structures of drug pairs.
  arXiv  Detail & Related papers  (2022-08-24T02:06:21Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
  We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI) MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively. Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
  arXiv  Detail & Related papers  (2022-03-28T05:44:29Z)
• Hierarchical Graph Representation Learning for the Prediction of Drug-Target Binding Affinity [7.023929372010717]
  We propose a novel hierarchical graph representation learning model for the drug-target binding affinity prediction, namely HGRL-DTA. In this paper, we adopt a message broadcasting mechanism to integrate the hierarchical representations learned from the global-level affinity graph and the local-level molecular graph. Besides, we design a similarity-based embedding map to solve the cold start problem of inferring representations for unseen drugs and targets.
  arXiv  Detail & Related papers  (2022-03-22T04:50:16Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• MolTrans: Molecular Interaction Transformer for Drug Target Interaction Prediction [68.5766865583049]
  Drug target interaction (DTI) prediction is a foundational task for in silico drug discovery. Recent years have witnessed promising progress for deep learning in DTI predictions. We propose a Molecular Interaction Transformer (TransMol) to address these limitations.
  arXiv  Detail & Related papers  (2020-04-23T18:56:04Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.